The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption

Arthritis Research

Volumn 3, Issue 1, 2001, Pages 6-12

  Gravallese, E M ^a   Galson, D L ^a   Goldring, S R ^a   Auron, P E ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Osteoclasts; RANK; RANKL; TNF ; TRAF

Indexed keywords

CYTOKINE; DIFFERENTIATION INDUCING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; LIGAND; LIPOPOLYSACCHARIDE; OSTEOPROTEGERIN; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

BONE EROSION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CYTOLOGY; HUMAN; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN FAMILY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BONE RESORPTION; CARRIER PROTEINS; CELL DIFFERENTIATION; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 4; TNF RECEPTOR-ASSOCIATED FACTOR 5; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 0035100960     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar134     Document Type: Review

References (64)

1. The erosive front: A topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head
2. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint
3. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
4. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
5. Osteoclast-like cells in murine collagen induced arthritis
6. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover
7. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone
8. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
9. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
10. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
11. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
12. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines
13. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
14. A novel molecular mechanism modulating osteoclast differentiation and function
15. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
16. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
17. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
18. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
19. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
20. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
21. RANK is essential for osteoclast and lymph node development
22. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
23. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
24. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
25. Characterization of structural domains of human osteoclastogenesis inhibitory factor
26. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
27. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
28. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation
29. Three-dimensional structure of a complex between the death domains of Pelle and Tube
30. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs)
31. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
32. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15α chain
33. Membrane localization of TRAF3 enables JNK activation
34. Crystallographic analysis of CD40 recognition and signaling by human TRAF2
35. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
36. The death domain kinase RIP mediates the TNF-induced NF-kappa B signal
37. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation
38. The biology of toll-like receptors
39. The interleukin 1 receptor: Ligand interactions and signal transduction
40. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase
41. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses
42. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
43. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB inducing kinase
44. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2
45. Requirement for NF-kappa B in osteoclast and B-cell development
46. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
47. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)
48. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
49. Tec kinases: A family with multiple roles in immunity
50. Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1
51. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
52. Rescue of osteoclast function by transgenic expression of kinase-deficient src in src-l-mutant mice
53. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
54. Etk, a BTK family tyrosine kinase, mediates cellular transformation by linking Src to Stat3 activation
55. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
56. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis
57. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts
58. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
59. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide
60. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor
61. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction
62. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
63. Involvement of receptor activator of nuclear factor kappa-B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
64. Activated T lymphocytes support osteoclast formation in vitro